Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
23.68
-0.77 (-3.15%)
Sep 10, 2026, 3:04 PM CST
SHE:300683 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 197.83 | 648.33 | 419.15 | 510.22 | 748.48 | 184.05 |
Short-Term Investments | - | 2.23 | 4.56 | 0.3 | 142.75 | 491.39 |
Trading Asset Securities | 196.94 | 170.63 | 449.69 | 578.71 | 144.04 | 514.4 |
Cash & Short-Term Investments | 394.77 | 821.19 | 873.4 | 1,089 | 1,035 | 1,190 |
Cash Growth | -46.55% | -5.98% | -19.81% | 5.21% | -12.99% | 18.99% |
Accounts Receivable | 291.64 | 298.58 | 300.78 | 254.58 | 233.21 | 264.48 |
Other Receivables | 3.61 | 0.11 | 0 | 0 | - | 3.18 |
Receivables | 295.26 | 298.69 | 300.78 | 254.58 | 233.21 | 270.15 |
Inventory | 84.57 | 82.94 | 108.98 | 117.41 | 120.18 | 71.65 |
Other Current Assets | 456.39 | 27.05 | 23.18 | 26.98 | 55.47 | 50.88 |
Total Current Assets | 1,231 | 1,230 | 1,306 | 1,488 | 1,444 | 1,583 |
Property, Plant & Equipment | 637.61 | 658.14 | 729.69 | 734.56 | 654.23 | 519.63 |
Long-Term Investments | 40.14 | 42.85 | 16.58 | 27.08 | 88.89 | 65.29 |
Goodwill | 178.59 | 178.59 | 263.59 | 263.59 | 302.15 | 316.17 |
Other Intangible Assets | 216.69 | 229.09 | 253.44 | 276.88 | 90.37 | 90 |
Long-Term Deferred Tax Assets | 127.04 | 120.52 | 119.94 | 109.47 | 80.59 | 71.64 |
Long-Term Deferred Charges | 32 | 34.51 | 34.49 | 31.96 | 2.62 | 2.39 |
Other Long-Term Assets | 8.2 | 82.97 | 212.57 | 39.51 | 43.87 | 49.87 |
Total Assets | 2,471 | 2,577 | 2,937 | 2,971 | 2,707 | 2,698 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 34.67 | 33.13 | 64.35 | 52.08 | 58.05 | 51.72 |
Accrued Expenses | 13.04 | 63 | 79.11 | 59.86 | 46.51 | 46.42 |
Short-Term Debt | 7.06 | 7.06 | 7.22 | 7.32 | 30.03 | 33.04 |
Current Portion of Long-Term Debt | 44.24 | 21.37 | 14.83 | 14.66 | 7.31 | 3.21 |
Current Portion of Leases | - | 0.93 | 5.12 | 4.8 | 0.7 | 1.87 |
Current Income Taxes Payable | 5.18 | 2.17 | 3.87 | 2.84 | 2.46 | 4.52 |
Current Unearned Revenue | 47.02 | 53.77 | 77.54 | 116 | 97.99 | 66.38 |
Other Current Liabilities | 130.83 | 127.41 | 111.21 | 88.58 | 41.68 | 42.09 |
Total Current Liabilities | 282.04 | 308.85 | 363.26 | 346.15 | 284.73 | 249.25 |
Long-Term Debt | - | - | 11.52 | 26.32 | 40.92 | 48.17 |
Long-Term Leases | 3.39 | 3.9 | 5.36 | 10.4 | 2.59 | 3.64 |
Long-Term Unearned Revenue | 85.41 | 83.04 | 84.25 | 30.47 | 27.9 | 22.59 |
Long-Term Deferred Tax Liabilities | 10.46 | 11.35 | 14.74 | 16.48 | 13.11 | 7.25 |
Other Long-Term Liabilities | - | - | 45.92 | 45.92 | 2.45 | 23.56 |
Total Liabilities | 381.3 | 407.14 | 525.05 | 475.73 | 371.7 | 354.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 130.89 | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 |
Additional Paid-In Capital | 1,837 | 1,837 | 1,837 | 1,837 | 1,557 | 1,557 |
Retained Earnings | 114 | 192.71 | 423.98 | 510.34 | 631.16 | 645.19 |
Total Common Equity | 2,082 | 2,161 | 2,392 | 2,478 | 2,310 | 2,324 |
Minority Interest | 7.69 | 8.87 | 19.8 | 17.37 | 24.79 | 18.65 |
Shareholders' Equity | 2,090 | 2,169 | 2,412 | 2,496 | 2,335 | 2,343 |
Total Liabilities & Equity | 2,471 | 2,577 | 2,937 | 2,971 | 2,707 | 2,698 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 54.69 | 33.26 | 44.05 | 63.5 | 81.55 | 89.92 |
Net Cash (Debt) | 340.08 | 787.93 | 829.35 | 1,026 | 953.73 | 1,100 |
Net Cash Growth | -51.45% | -4.99% | -19.14% | 7.55% | -13.29% | 10.72% |
Net Cash Per Share | 2.60 | 6.03 | 6.34 | 7.90 | 7.48 | 10.34 |
Filing Date Shares Outstanding | 134.32 | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 |
Total Common Shares Outstanding | 134.32 | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 |
Working Capital | 948.94 | 921.02 | 943.07 | 1,142 | 1,159 | 1,333 |
Book Value Per Share | 15.50 | 16.51 | 18.27 | 18.93 | 18.92 | 19.04 |
Tangible Book Value | 1,687 | 1,753 | 1,875 | 1,938 | 1,918 | 1,918 |
Tangible Book Value Per Share | 12.56 | 13.39 | 14.32 | 14.80 | 15.71 | 15.71 |
Buildings | - | 503.22 | 500.14 | 500.38 | 398.72 | 350.14 |
Machinery | - | 521.43 | 528.75 | 480.61 | 339.05 | 291.83 |
Construction In Progress | - | 7.36 | 11.02 | 2.99 | 120.99 | 34.27 |